Suzhou Jingyu Medical Equipment

About Suzhou Jingyu Medical Equipment

Suzhou Jingyu Medical Equipment Co., Ltd., operating as SceneRay, is a medical device company established in 2009 that develops, produces, and sells deep brain stimulation (DBS) systems. The company was founded by Yihua Ning, who serves as the CEO. Ning has over 30 years of experience in the medical device field, having held positions at companies like Medtronic and Siemens before founding SceneRay.

The company's core business revolves around its proprietary deep brain stimulation technology aimed at treating neurological and psychiatric disorders. Its primary product is the SceneRay DBS system, which includes implantable pulse generators (IPGs), electrodes, and programming technology for conditions such as Parkinson's disease and opioid addiction. The system features several distinct technologies, including the ability to deliver different stimulation frequencies to each side of the brain, a patented lead fixture to prevent electrode displacement, and high-speed wireless programming. A key feature is its remote programming follow-up system, which allows clinicians to adjust patient devices remotely, reducing the need for travel.

SceneRay's product for opioid addiction was the first of its kind to be approved by China's 'Innovative Green Channel' in 2017 and received a Breakthrough Device designation from the U.S. FDA in 2022. The company collaborates with various hospitals and universities on clinical trials to validate and improve its therapies. SceneRay has raised a total of $62.6 million over two funding rounds, with major investors including Sequoia Capital China and Hillhouse Ventures.